Silvia Pujals Riatós

Silvia Pujals Riatós is a Researcher at the Core Facilities Unit of the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, Spain, where she leverages advanced microscopy and nanomaterial characterization expertise to drive innovation in nanomedicine. Her dual role combines facility management with active research in developing next-generation nanocarriers for biomedical applications, particularly in drug delivery and cellular imaging.

Her research spans nanomedicine, supramolecular chemistry, and super-resolution microscopy, with emphasis on designing light-activated drug delivery systems, quantifying nanoparticle behavior in biological environments, and engineering tumor-targeted nanotherapeutics. Key focus areas include supramolecular polymers, protein corona analysis, and real-time monitoring of nanocarrier dynamics in complex microenvironments like tumor-on-a-chip models. Her work bridges synthetic chemistry, materials science, and translational medicine to address challenges in cancer therapy and neurodegenerative diseases.

Analysis of her 15 most recent publications (2021-2025) reveals three dominant trends: (1) Quantitative characterization of nanomaterial-biological interactions using cutting-edge microscopy techniques like DNA-PAINT and Glyco-PAINT, (2) Development of stimuli-responsive supramolecular systems with optimized stability-release profiles, and (3) Application of engineered nanocarriers in tumor models and cellular activation systems. Collaborations with the Albertazzi group and international teams demonstrate her integrative approach to solving biomedical challenges.

As a core facility leader, Dr. Pujals provides critical infrastructure support for IBEC's research ecosystem, enabling high-impact studies through advanced nanomaterial analysis and super-resolution imaging services. Her facility work underpins projects ranging from fundamental protein interaction studies to preclinical cancer models, fostering interdisciplinary innovation across the institute.